Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology

Thomas Perkmann, Thomas Koller, Nicole Perkmann-Nagele, Maria Ozsvar-Kozma, David Eyre, Philippa Matthews, Abbie Bown, Nicole Stoesser, Marie-Kathrin Breyer, Robab Breyer-Kohansal, Otto C Burghuber, Slyvia Hartl, Daniel Aletaha, Daniela Sieghart, Peter Quehenberger, Rodrig Marculescu, Patrick Mucher, Astrid Radakovics, Miriam Klausberger, Mark DuerkopBarbara Holzer, Boris Hartmann, Robert Strassl, Gerda Leitner, Florian Grebien, Wilhelm Gerner, Reingard Grabherr, Oswald F Wagner, Christoph J Binder, Helmuth Haslacher

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung


Background Serological tests are widely used in various medical disciplines for diagnostic and monitoring purposes. Unfortunately, the sensitivity and specificity of test systems are often poor, leaving room for false-positive and false-negative results. However, conventional methods were used to increase specificity and decrease sensitivity and vice versa. Using SARS-CoV-2 serology as an example, we propose here a novel testing strategy: the ‘sensitivity improved two-test’ or ‘SITtexttwosuperior’ algorithm.Methods SITtexttwosuperior involves confirmatory retesting of samples with results falling in a predefined retesting zone of an initial screening test, with adjusted cut-offs to increase sensitivity. We verified and compared the performance of SITtexttwosuperior to single tests and orthogonal testing (OTA) in an Austrian cohort (1117 negative, 64 post-COVID-positive samples) and validated the algorithm in an independent British cohort (976 negatives and 536 positives).Results The specificity of SITtexttwosuperior was superior to single tests and non-inferior to OTA. The sensitivity was maintained or even improved using SITtexttwosuperior when compared with single tests or OTA. SITtexttwosuperior allowed correct identification of infected individuals even when a live virus neutralisation assay could not detect antibodies. Compared with single testing or OTA, SITtexttwosuperior significantly reduced total test errors to 0.460.24textendash0.65) or 1.600.94textendash2.38) at both 50CoV-2 serology, SITtexttwosuperior proved to be the best diagnostic choice at both 50% seroprevalence in all tested scenarios. It is an easy to apply algorithm and can potentially be helpful for the serology of other infectious diseases.Data are available upon reasonable request. Data are available to interested researchers upon request from the corresponding author.
Seiten (von - bis)770-777
FachzeitschriftJournal of Clinical Pathology
PublikationsstatusVeröffentlicht - 1 Nov. 2023
Extern publiziertJa


Untersuchen Sie die Forschungsthemen von „Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren